1,619 results on '"Arroyo, Vicente"'
Search Results
2. Palmitoylcarnitine impairs immunity in decompensated cirrhosis
3. Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis
4. Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure
5. Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure
6. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
7. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure
8. Renal Circulation and Pathogenesis of Functional Renal Failure in Cirrhosis*
9. List of contributors
10. Sepsis and the liver
11. WED-112 Plasma extracellular vesicles improve prediction of 90 day mortality in patients with acute decompensation of cirrhosis
12. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
13. THU-049 Supplemental low-dose hydrocortisone in cirrhotic patients with septic shock: a double-blind, randomised, placebo-controlled, multicentre trial; the SCotCH study
14. THU-050 Urinary biomarkers of tubular and glomerular damage predict renal recovery in patients with hepatorenal syndrome-acute kidney injury
15. WED-098-YI Low-density lipoprotein can predict hospital readmissions and outcomes following acute decompensation of cirrhosis
16. THU-057-YI Distinguishing clinical profiles in acute-on-chronic liver failure: a comparative analysis of alcohol-related hepatitis versus infection precipitated acute-on-chronic liver failure
17. THU-055 Differential impact of proton pump inhibitors, statins, and nonselective beta-blockers on survival in different stages of chronic liver disease
18. TOP-084 Galectin 9 predicts clinical outcome and regulates immune dysfunction in acute-on-chronic liver failure
19. LBP-012 Epidemiological trends and clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis across Latin America: results from the ACLARA study
20. FRI-121 Safetyand tolerability of long-term albumin treatment in patients with decompensated cirrhosis
21. FRI-039 Terlipressin therapy is associated with increased risk of colonization with multidrug-resistant bacteria in patients with decompensated cirrhosis
22. WED-059 Effects of albumin treatment on cell death markers in patients with decompensated cirrhosis and in acute-on-chronic liver failure
23. OS-011 The linoleic acid-derived leukotoxin 9, 10-DiHOME drives immunosuppression in patients with acute-on-chronic liver failure
24. LBP-026 The global prospective observational study to evaluate the role of ‘liver transplantation in patients with cirrhosis and severe acuteon-chronic liver failure (CHANCE)’: study design, demographics and overall outcome
25. WED-087 Exploring the potential of human serum albumin to reprogram B cell function
26. LBO-004 Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
27. TOP-073 Extensive characterization of new biomarkers associated with infection and outcome of decompensation of cirrhosis using high throughput metabolomics, lipidomics and cytokinomics
28. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis
29. Prognosis algorithms for acute decompensation of cirrhosis and ACLF
30. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)
31. Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
32. Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure
33. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
34. LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis.
35. The role of RIPK1 mediated cell death in acute on chronic liver failure
36. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides
37. Immunosuppression and Increased Risk of Bacterial Infections in Cirrhosis
38. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
39. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
40. Cirrhosis and ascites
41. Liver Failure, Acute-on-Chronic
42. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
43. Complicaciones graves en las colonoscopias de cribado del cáncer colorrectal en la Comunidad Valenciana
44. The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
45. Pathophysiological biomarkers associated with resolution of ACLF in patients treated with the liver dialysis device, DIALIVE
46. Distinct immunometabolic signatures in circulating immune cells define disease outcomes in acute-on-chronic liver failure
47. Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection
48. 76 - Hepatorenal Syndrome
49. Acute-on-Chronic Liver Failure
50. P-3 PLASMA EXCHANGE WITH ALBUMIN INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.